GlassScriptPhysician profile
Kirk Lammi
NPI 1851575344
$1,517.48
in general payments reported to CMS, 2019-2025
29 companies · $251 in 2025
The $251 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $137 · 2021: $275 · 2022: $252 · 2023: $186 · 2024: $126 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $564.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $563.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $278.58 | 2020-2023 | |
| Evofem Biosciences, INC. | $126.35 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $108.56 | 2019-2025 | |
| Exeltis, USA INC. | $104.46 | 2020-2024 | Slynd |
| Organon LLC | $95.94 | 2021-2024 | Nexplanon |
| Hologic Sales and Service, LLC | $79.55 | 2019-2025 | Omni Hysteroscope, Myosure Tissue Removal Device |
| Duchesnay USA Incorporated | $65.03 | 2019 | |
| Astellas Pharma US INC | $56.81 | 2019-2024 | Veozah |
| Ethicon US, LLC | $54.03 | 2019-2025 | Vistaseal, Stratafix |
| Baxter Healthcare | $52.87 | 2025 | Perclot |
| Biogen, INC. | $49.76 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $44.10 | 2024-2025 | Gemtesa |
| Merck Sharp & Dohme LLC | $39.81 | 2019 | |
| Therapeuticsmd, INC. | $39.51 | 2019-2021 | |
| Myovant Sciences INC. | $38.67 | 2021-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $33.61 | 2019-2020 | |
| Allergan, INC. | $29.44 | 2019 | |
| Agile Therapeutics, INC. | $28.60 | 2021 | |
| Neuronetics, INC. | $26.20 | 2025 | Neurostar Tms Therapy System |
| Daiichi Sankyo INC. | $24.59 | 2022 | |
| Intuitive Surgical, INC. | $24.35 | 2024 | |
| Solventum Corporation | $19.20 | 2025 | Prevena |
| Pfizer INC. | $18.45 | 2023 | |
| Novo Nordisk INC | $15.94 | 2024 | Wegovy |
| Minerva Surgical, INC | $14.34 | 2019 | |
| Avion Pharmaceuticals | $13.09 | 2022 | |
| Agiliti Surgical, INC. | $12.73 | 2019 | |
| Lupin INC. | $12.12 | 2019 | |
| Meditrina | $10.79 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Lammi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.